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Abstract
Background: Optimising the fluid resuscitation of patients with severe malaria is a simple and potentially cost-effective
intervention. Current WHO guidelines recommend central venous pressure (CVP) guided, crystalloid based, resuscitation in
adults.
Methods: Prospectively collected haemodynamic data from intervention trials in Vietnamese adults with severe malaria
were analysed retrospectively to assess the responses to fluid resuscitation.
Results: 43 patients were studied of whom 24 received a fluid load. The fluid load resulted in an increase in cardiac index
(mean increase: 0.75 L/min/m
2 (95% Confidence interval (CI): 0.41 to 1.1)), but no significant change in acid-base status post
resuscitation (mean increase base deficit 0.6 mmol/L (95% CI: 20.1 to 1.3). The CVP and PAoP (pulmonary artery occlusion
pressure) were highly inter-correlated (rs=0.7, p,0.0001), but neither were correlated with acid-base status (arterial pH,
serum bicarbonate, base deficit) or respiratory status (PaO2/FiO2 ratio). There was no correlation between the oxygen
delivery (DO2) and base deficit at the 63 time-points where they were assessed simultaneously (rs=20.09, p=0.46).
Conclusions: In adults with severe falciparum malaria there was no observed improvement in patient outcomes or acid-
base status with fluid loading. Neither CVP nor PAoP correlated with markers of end-organ perfusion or respiratory status,
suggesting these measures are poor predictors of their fluid resuscitation needs.
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Introduction
The introduction of artemisinin-based therapies has revolu-
tionised the care of patients with malaria. The mortality of severe
malaria in Asian adults was reduced by 35% with parenteral
artesunate treatment compared with the previous standard
parenteral quinine [1]. However, even with intravenous artesu-
nate treatment, 15 to 25% of adult patients with severe malaria
will die;the majorityduring thefirst48 hoursoftheirhospitalisation
[1]. No adjunctive chemotherapy has been shown to be of benefit in
severe falciparum malaria and there are surprisingly few clinical
data regarding the optimal supportive care of patients in the early
stages of their hospitalisation [2,3]. In contrast impressive impro-
vements in mortality have been demonstrated using early goal-
directed therapy in patients with sepsis [4] and, in resource poor
settings,withsimple fluid resuscitation protocols indenguefever[5].
Indeed, even using quinine treatment, patients with severe malaria
admitted to an excellent French intensive care unit had a mortality
rate of 11% [6], suggesting that improved supportive care can lead
to better outcomes in malaria as well.
Small series have confirmed that some adult patients with severe
malaria are hypovolaemic, or at least have a reduced effective
circulating volume [7,8]. This hypovolaemia has the potential to
exacerbate renal failure and lactic acidosis, two of the most
significant contributors to mortality in severe malaria [9]. It might
be expected that prompt fluid resuscitation would improve acidosis
and pre-renal renal failure and therefore improve outcomes. By
analogy early goal directed fluid resuscitation is a key feature of
international sepsis guidelines [10]. However, non-cardiogenic pulmo-
nary oedema is also a manifestation of severe malaria in adults and
with a mortality rate of 80% in resource-poor settings [11], physicians
have tended to err on the side of caution with fluid replacement.
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is clearly preferred [12]. However, whilst there are theoretical
advantages in using colloid rather than crystalloid as a resuscita-
tion agent [13], in a recent trial of critically ill African children –
the majority of whom had severe malaria – those resuscitated
aggressively with colloid and crystalloid had equally poor
outcomes [14], and had a higher mortality than those managed
conservatively. Furthermore while there are no data for adults
with severe malaria, in a heterogeneous population of adults
admitted to well equipped and well staffed intensive care units
(ICU) with a range of non-malarious conditions there was no
advantage in resuscitating these patients with albumin compared
to crystalloid [15].
With few data to guide them, WHO guidelines emphasise
the physical examination of patients; ‘‘If there is evidence (on
physical examination) of dehydration, give only isotonic fluid
(0.9% saline) by intravenous infusion, but avoid circulatory
overload as it may rapidly precipitate fatal pulmonary oedema’’
[16]. Others have pointed out that, in the absence of precipitous
fluid loss such as in cholera, in severe infections there is often little
correlation between the physical assessment of hypovolaemia and
true volume status [17]. Tacitly acknowledging this, the WHO
guidelines also suggest that patients with severe malaria should,
if possible, have a central line inserted and the central venous
pressure (CVP) should be used to assist in the assessment of
volume status [16].
To characterise the effects of fluid resuscitation in adults with
severe malaria, we reviewed retrospectively the clinical and
biochemical data of patients with severe malaria who were
enrolled in prospective haemodynamic studies. We aimed to
determine whether there was any evidence for improved outcomes
when patients in these studies were resuscitated with normal saline
or colloid. We also assessed the utility of central venous pressure
(CVP) and pulmonary artery occlusion pressure (PAoP) as
measures of volume status and thus fluid requirements in patients
with severe malaria.
Methods
Ethics statement
Written informed consent was obtained from each patient or, in
the case of comatose patients, their attendant relative. All studies
were approved by the Ethical and Scientific Committee of the
Hospital for Tropical Diseases. As the fluid resuscitation of
patients guided by invasive pressure measurements represented
standard of care at the time, consent was not specifically sought for
the collection of data for this retrospective chart review.
Patient selection
The original studies were carried out in a purpose-built
intensive care unit at the Hospital for Tropical Diseases in Ho
Chi Minh City, a hospital that acts as an infectious disease referral
centre for much of southern Viet Nam. In 1993 a purpose built
intensive care unit for the management of severe malaria was built
and equipped for haemodynamic monitoring. Patients were
included in this review if they had invasive haemodynamic
monitoring performed as part of the initial study. They were
considered to have severe malaria if they had asexual forms of
Plasmodium falciparum on their peripheral blood smear and at least
one of the following criteria of severity: acute renal failure with
oliguria and plasma creatinine of .3 mg/dL (265 mmol/L);
hypoglycaemia (plasma glucose, ,40 mg/dL (2.2 mmol/L));
shock with systolic blood pressure of ,80 mm Hg; metabolic
acidosis with a base deficit of .10 mmol/L; venous plasma lactate
of .4 mmol/L; or pulmonary oedema [18]. These criteria are a
stricter modification of the widely used World Health Organisa-
tion criteria for severe malaria [19].
Patient management
A full history was taken from either the patient or the attendant
relatives and a detailed physical examination was performed. The
patient was weighed, and body length was recorded. Baseline
blood samples were taken for full haematology, quantitative
parasite count, clotting studies, biochemistry (including arterial
and venous gases, pH, plasma lactate and glucose), and blood
cultures.
An arterial catheter was inserted into the femoral artery, and
a flow-directed pulmonary artery catheter (Abbott Laboratories,
North Chicago, IL) was introduced via the internal jugular route
under fluoroscopy. Continuously monitored intravascular pres-
sures (arterial pressure, CVP, PAoP), electrocardiogram, and
oximetric oxygen saturation were recorded on a multifunction
monitor (Hewlett-Packard, Palo Alto, CA). PAoP was measured
intermittently. Cardiac output was determined by thermodilu-
tion in triplicate using 10 mL boluses of cooled 5% dextrose.
Body temperature was recorded a st h ec o r et e m p e r a t u r ef r o m
the pulmonary artery catheter terminal thermistor. Simulta-
neous arterial and mixed venous plasma lactate and glucose
concentrations were determined enzymatically using dedicated
o n - l i n ea n a l y s e r s( A n a l o x ,L o n d o n ,U K ) .S y s t e m i cv a s c u l a r
resistance, oxygen delivery (DO2), and oxygen consumption
(VO2) were calculated and cardiaci n d e x ,s y s t e m i cv a s c u l a r
resistance index, DO2 index, and VO2 index derived using
standard formulae [20]. Preparation of the patient and
recording of baseline hemodynamic and metabolic measure-
ments took 45–120 mins and did not interfere with other aspects
of clinical management.
Depending on the study in which they were enrolled, patients
received either an intramuscular quinine-loading dose regimen
(20 mg/kg quinine dihydrochloride salt followed by 10 mg/kg,
eight hourly), intramuscular artemether treatment (4 mg/kg stat
followed by 2 mg/kg, eight hourly) (both drugs: Kunming
Pharmaceutical Company, Kunming, People’s Republic of China)
or artesunate (Guilin Pharmaceutical Factory, Guangxi, People’s
Republic of China) 2.4 mg/kg iv stat, followed by 1.2 mg/kg at 12
and 24 hrs daily [18,21]. The initial requirement for fluids was
assessed clinically based on jugular venous pressure, peripheral
perfusion and urine output supported subsequently by CVP and
PAoP measurements. The PAoP is an indirect measure of the filling
pressure of the left side of the heart and thus a gauge of volume
status. According the Frank-Starling principle increasing the heart’s
filling pressure will lead to a greater cardiac output and hence tissue
perfusion [22] (figure 1). Depending on the extent of estimated
hypovolaemia and tissue hypoperfusion, patients received normal
saline, a synthetic colloid (Gelofundin, B. Braun Medical, Metsun-
gen, Germany) or no fluid loading consistent with the prevailing
clinical practice of the time. Patients who received fluid loading
were resuscitated to a PAoP of 9–12 mmHg. Full haemodynamic
measurements including PAoP and cardiac output were made
approximately every 30 mins during resuscitation, though the right
atrial and arterial blood pressures were monitored continuously. In
cases of shock refractory to fluid loading inotropic support with
either dopamine or adrenaline was given. Oxygen was given as
necessary, but the patients were not routinely mechanically
ventilated as there was limited access to ventilatory support. Renal
replacement was with either peritoneal dialysis or veno-venous
haemofiltration.
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Results were entered into a database (Microsoft Excel, Microsoft
Corp, USA) and analysed with a statistical software package
(Stata 9.2, StataCorp, College Station, Texas, USA). Correlation
coefficients were determined using Spearman’s method. Differ-
ences between groups were analyzed using the Kruskal-Wallis and
Fisher’s exact tests.
Results
Overall there were 43 patients with severe falciparum malaria
who had haemodynamic data available for analysis; 11 were
admitted with haemodynamic shock, 11 had pulmonary oedema,
and 30 met WHO criteria for malaria associated acute renal
failure. Their management is recorded in figure 2.
The mean Glasgow Coma Scale (GCS) was 9 (95% CI: 8 to 10),
the mean base deficit was 10.7 mmol/L (95% CI: 9 to 12.5) and
the mean arterial lactate was 6.2 mmol/L (95% CI: 5.1 to 7.3).
Fifteen patients died during their hospitalisation. On univariate
analysis acid-base status on admission was a strong predictor of
death: patients with a base deficit of greater than 10 mmol/L had
4 times the risk of death of those with base deficit less than
10 mmol/L (95%CI 1.01–15.86, p=0.049). Patients with a
plasma bicarbonate of less than 15 mmol/L had 6.5 times the
risk of death of those with a bicarbonate of greater than 15 mmol/
L (95% CI 1.4–29.7, p=0.02). Logistic regression using purposeful
selection in a model incorporating antimalarial drug used, GCS,
PaO2/FiO2 ratio, plasma creatinine, total bilirubin, peripheral
parasite count, age, haematocrit, cardiac index, lactate and arterial
pH confirmed that acid base status, as determined by the arterial
pH, was the only significant predictor of outcome.
Fluid loading
Twenty four (56%) of the patients received a fluid load and
nineteen (44%) did not. The PaO2/FiO2 ratio and the CVP and
PAoP were the only variables that were statistically significantly
different between these two groups (the PAoP was used to
determine whether a fluid load would be given, and the CVP was
highly correlated with the PAoP (r,0.0001, rs=0.75)) (table 1).
The median volume of fluid administered was 918 mls (range
350–2000), and it was delivered over a median of 75 minutes
(range 30 minutes to 3 hours 45 minutes). All the patients who
later died completed their fluid loading.
With a fluid load there was a significant mean increase (95% CI)
in Cardiac Index: 0.75 L/min/m
2 (0.41–1.1), PAoP: 5 mmHg (3–
6) CVP: 3 mmHg (1–4) and mixed venous oxygen saturation
(CvO2) 4.4% (1.5–7.4), and a significant mean (95% CI) decrease
in systemic vascular resistance (SVR) 2242 dyne/s/cm
25 m
2
(2380 to 2104), oxygen consumption (VO2) 213 mL/min/
m
2(228 to 21.8) and the oxygen extraction ratio (OER) 24.6%
(27.7 to 21.4). There was a significant decrease in haemoglobin
(median, interquartile range) 20.7 g/dL (21.6 to 20.1). Notably
there was no significant change in the acid-base status of the
patients or their clinical outcomes (see tables 2 and 3).
Figure 1. Cardiac function curve showing the relationship between preload and stroke volume (noting that cardiac output=heart
rate 6stroke volume). At a lower preload the stroke volume is highly sensitive to changes in preload. At a higher preload, further increases in
preload lead to a reduced increase in stroke volume (the Frank-Starling mechanism). Stroke volume is also increased in the setting of increased
sympathetic nervous system activation or exogenously administered inotropes. A: At rest in a person with a normal heart B: Increased sympathetic
nervous system activation or exogenously administered inotropic therapy.
doi:10.1371/journal.pone.0025523.g001
Fluid Management of Adults with Severe Malaria
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e25523Twenty two patients (92%) had the fluid that was used as the
resuscitation agent recorded; twelve of these patients received
normal saline and ten received gelofundin. The group that
received gelofundin were sicker with a lower MABP, pH, and a
greater base deficit and arterial lactate. Despite this, patients
receiving gelofundin had a similar mortality rate to those receiving
normal saline (tables 4, 5).
Patients receiving gelofundin had a significantly greater increase
in the cardiac index than those patients who received normal
saline as the resuscitation fluid. Patients who received the colloid
had a mean increase of 1.32 L/min/m
2 (95% CI 0.69–1.94) as
compared with a mean increase of 0.35 L/min/m
2 (95% CI 0.1–
0.61) in the patients who received normal saline (p=0.006),
although there was no difference in the volume of fluid (median
(interquartile range) that the two groups received: normal saline
818 ml (500–1190), Gelofundin 1000 ml (500–1000) (p=0.97).
However, this increase in cardiac index did not translate into a
statistically significant improvement in the DO2, CvO2,V O 2, pH,
base deficit or lactate (Table 6 and figure 3)
There was no relationship between the volume of fluid
administered and the patient’s outcome or the patient’s likelihood
of developing shock, renal failure or pulmonary oedema. There
was a significant relationship between the volume of fluid infused
and the changes in the cardiac index (p=0.04, rs=0.41), fall in
haemoglobin (p=0.03, rs=20.44), and the SVR (p,0.001,
rs=20.63). However, there was no relationship between the
volume of fluid infused and the changes in acid - base status (DBD
p=0.15 rs=20.37, Dlactate p=0.39 rs=20.21, DHCO3
p=0.19 rs=20.34, DpH p=0.32 rs=20.23).
Haemodynamic variables and acid-base status
There was no relationship between the CVP and PAoP on
admission and cardiac output, oxygen delivery or acid/base status.
After volume loading there was still no relationship between CVP
and PAoP and these measures. The increase in CVP and PAoP
with resuscitation was correlated with the increase in cardiac
index, but there was no association between the change in CVP
and PAoP and the changes in any other markers (see table 7).
Pressures and fluid volume requirements
A PAoP of 9–12 was used as the target for the resuscitation in
those patients that received a fluid load. The baseline PAoP was
correlated with the volume of fluid that was required to achieve
this endpoint (p=0.001, rs=20.57). However there was a great
deal of overlap in these values, for instance in the 5 patients with a
baseline PAoP of 4 mmHg, between 800 ml and 2000 ml of fluid
was required to raise the PAoP to the target range. There was no
relationship between the baseline CVP and the volume of fluid
that was required to resuscitate the patient (see figure 4).
There was no significant difference between the CVP of the
patients who did and did not have pulmonary oedema on
admission. The median CVP (95% CI) of patients both with
(n=11) and without pulmonary oedema (n=32) was 3 mmHg
95% (CI: 0.7–4.2 and 2–4 respectively, p=0.89 for a difference).
Similarly there was no statistical difference in the PAoP of the two
groups: the median PAoP (95% CI) was 9 mmHg (4–11) in
patients with pulmonary oedema and 7 mmHg (6–8) in those
without the complication (p=0.71 for a difference). There were
only two patients who subsequently developed pulmonary oedema
during their hospitalisation. Examination of the 56 time points in
all patients for which there were simultaneous CVP, PAoP and
PaO2/FiO2 measurements, revealed no relationship between
either CVP (p=0.55) or PAoP (p=0.77) and gas exchange.
When the simultaneous assessments of macrovascular function
and acid base status of all patients were pooled, there were 76 time
points for which data were available. There was no relationship
between the oxygen delivery and the prognostic markers of pH,
bicarbonate or base deficit. There was a correlation between the
Figure 2. Management of the patients.
doi:10.1371/journal.pone.0025523.g002
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bicarbonate (p=0.01, rs=0.34), and base deficit (p=0.02,
rs=0.31), although if the 8 data-points where the MABP was less
than 60 were removed, there was no longer a correlation: pH
(p=0.7, rs=0.05), bicarbonate (p=0.31, rs=0.15), and base
deficit (p=0.46, rs=0.11).
Discussion
There has been considerable discussion as to the optimum fluid
management of severe malaria. This small series was not powered
to detect outcome differences between the treatment groups, but it
provides important information on the haemodynamic and
metabolic consequences of fluid administration to adults with
severe malaria. There was no evidence that fluid loading improved
the underlying pathological processes in severe malaria.
The rationale for fluid loading would be to improve microvas-
cular perfusion and thus reduce the acidosis which has consistently
been shown to be the strongest predictor of outcome in severe
malaria [9,23]. Once again in our series, acid base status was the
strongest predictor of death. However, in the 21 patients who had a
base deficit and bicarbonate measured before and after their fluid
loading, the median values of these variables actually worsened.
Patients who received a fluid load did have a rise in their cardiac
index, and most had a rise in their oxygen delivery, so how do we
Table 1. Baseline demographics of the patients, all values are
means (95% CI).
Variable
Fluid load
n=24
No fluid
load n=19 P value*
Age (years) 37.7 (31.6–43.8) 35.4 (26.7–44.2) 0.39
Male (%) 21/24 (88%) 15/19(79%) 0.68
Parasite count (610
3/ml) 233 (101–365) 92.8 (36.6–149) 0.17
Glasgow Coma Score 8 (6–10) 10 (8–11) 0.15
Sodium (mmol/L) 132 (128–135) 136 (131–141) 0.16
Potassium (mmol/L) 4.1 (3.8–4.5) 4.2 (3.9–4.6) 0.63
Creatinine (mmol/L) 408 (308–508) 364 (242–486) 0.39
pH 7.33 (7.29–7.38) 7.29 (7.22–7.35) 0.12
Bicarbonate (mmol/L) 14 (11.8–16.2) 14 (11.7–16.3) 0.99
Base deficit (mmol/L) 10.3 (8–12.5) 11.3 (8.2–14.3) 0.78
Lactate (mmol/L) 6.2 (4.5–7.8) 6.2 (4.5–7.9) 0.52
Total bilirubin (mmol/L) 136 (98–173) 116 (74–160) 0.48
Haemoglobin 9.0 (7.9–10) 9.4 (7.8–10.9) 0.45
Renal failure
Y 18/24 (75%) 12/19 (63%) 0.51
Anuric
V 11/24 (46%) 8/19 (42%) 1
Shock
# 6/24 (25%) 5/19 (26%) 0.72
Pulmonary oedema‘ 4/24 (18%) 7/19 (37%) 0.17
MABP (mmHg) 77.9 (71.9–83.8) 78.4 (68.2–88.7) 0.59
CVP (mmHg) 2 (1–3) 4.5 (3–6) 0.005
PAoP (mmHg) 6 (4–7) 10 (8–12) 0.001
Cardiac index (L/min/m
2) 4.0 (3.5–4.5) 4.0 (3.4–4.6) 0.91
SVR (dyne/s/cm
25 m
2) 1633 (1375–1891) 1589 (1299–1879) 0.86
Oxygen saturation (%) 96 (95–97) 95 (93–97) 0.24
PaO2/FiO2 ratio 456 (398–513) 286 (164–407) 0.02
CvO2 (%) 58.7 (54.3–62.9) 57.1 (52.2–62) 0.57
DO2 (mL/min/m
2) 447 (393–502) 449 (386–512) 0.99
VO2 (mL/min/m
2) 164 (151–178) 171 (148–194) 0.52
OER % 39 (34.6–42.4) 39.6 (34.6–44.6) 0.83
*p test by Kruskal Wallis, except.
Fisher’s exact.
YAdmission serum creatinine.265 mmol/L.
V,50 ml urine output in first 24 hours.
#Systolic blood pressure ,80 mmHg with evidence of poor end organ
perfusion.
‘Clinician’s diagnosis.
MABP: Mean arterial blood pressure, PAoP: Pulmonary artery occlusion
pressure, SVR: systemic vascular resistance, CvO2: mixed venous oxygen
saturation. DO2: Oxygen delivery. VO2: Oxygen consumption. OER: oxygen
extraction ratio.
doi:10.1371/journal.pone.0025523.t001
Table 2. Outcome by fluid load.
Fluid load No fluid load p value*
Died 9/24 38% 6/19 32% 0.76
APO developed‘ 1/24 4.2% 1/19 5.3% 1
CM developed‘ 0/24 0% 3/19 16% 0.08
ARF developed
Y 3/24 13% 1/19 5.3% 0.62
Shock developed
# 5/24 21% 6/19 32% 0.5
*p value determined by Fisher’s exact. APO: Acute pulmonary oedema, CM:
cerebral malaria ARF: Acute renal failure.
Yserum creatinine.265 mmol/L.
‘Clinician’s diagnosis.
#Systolic blood pressure ,80 mmHg with evidence of poor end organ
perfusion.
doi:10.1371/journal.pone.0025523.t002
Table 3. Change in variables with fluid loading n=24.
Variable Mean D 95% CI
DMABP (mmHg) 2 21t o6
DCVP (mmHg) 3 1 to 4
DPAoP (mmHg) 5 3 to 6
D Cardiac index (L/min/m
2) 0.75 0.41 to 1.1
DDO2 (mL/min/m
2)2 6 22t o5 4
D SVR (dyne/s/cm
25 m
2) 2242 2380 to 2104
DSaO2 (%) 0 0 to 1
DpO2/FiO2 25.2 237 to 27
DPaO2 mmHg 24 215 to 8
DPaCO2 mmHg 1 21t o2
D Haemoglobin (g/dL)* 20.7 21.6 to 20.1
D CvO2 (%) 4.4 1.5 to 7.4
DVO2 (mL/min/m
2) 213 228 to 21.8
DO2er (%) 24.6 27.7 to 21.4
D pH 20.01 20.02 to 0
DBicarbonate (mmol/L)* 20.1 21t o1
DBase deficit (mmol/L) 0.6 20.1 to 1.3
DLactate (mmol/L) 20.1 20.4 to 0.6
MABP: mean arterial blood pressure, CVP: central venous pressure, PAoP:
pulmonary artery occlusion pressure, SVR: systemic vascular resistance, SaO2:
oxygen saturation, PaO2: partial pressure of oxygen, PaCO2: partial pressure of
carbon dioxide, CvO2: mixed venous oxygen saturation, DO2: oxygen delivery,
VO2: oxygen consumption, O2er: oxygen extraction ratio.
*Median (IQR) as non-parametric distribution.
doi:10.1371/journal.pone.0025523.t003
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obstruction of the microvasculature is central to the pathophys-
iology of severe malaria, and is a direct cause of acidosis
[24,25,26]. Whilst fluid loading improves macrovascular status,
it does little to overcome the synchronous microvascular
sequestration. When data were pooled in this series there was no
statistical correlation between cardiac index, oxygen delivery and
the markers of acidosis.
These systemic metabolic data parallel the findings of our
investigations of renal blood flow and metabolism in severe
malaria. Pharmacological increases in renal blood flow with
dopamine were not associated with improvements in renal
function [27].
Perhaps the patients were given inadequate volumes of
resuscitation fluid in this study? It would seem unlikely. After
fluid loading the cardiac index improved a median of 15% (95%
CI 5.4–21.5) and nearly 90% of patients had a normal cardiac
index. Even if the analysis is limited to the patients who had a low
DO2 before resuscitation the median change in BD was 0 (95% CI
-1–2.5), suggesting that fluid loading is not improving the impaired
tissue perfusion contributing to pathology and to outcome.
Another possible explanation for the lack of improvement in
acid-base status is the possibility that any improvement in the
acidosis resulting from hypoperfusion has been offset by a
hyperchloraemic metabolic acidosis induced by resuscitation with
chloride rich saline and Gelofundin. In recent years, use of the
physicochemical Stewart approach to acid base disturbance [28]
has increased the awareness that resuscitation with fluid containing
supraphysiological chloride concentrations, can lead to metabolic
acidosis through a reduction in the strong ion difference of plasma.
Although the hyperchloraemic acidosis associated with resuscita-
tion has not been conclusively linked to deleterious sequelae, it has
been implicated in neurological dysfunction, coagulopathy,
cardiac dysfunction, renal dysfunction and haemolysis [29].
Unfortunately in this series we lack sufficient data to make an
assessment of the acidosis using the Stewart approach to elucidate
this relationship further.
Another concern with fluid loading is that it may be deleterious
in itself. It does not overcome the mechanical obstruction in the
microcirculation, but with the increased pulmonary capillary
permeability present in severe malaria [11,30], it may increase the
risk of pulmonary oedema - a complication with a dismal
prognosis in the resource poor setting. However in this small
series, only two patients developed pulmonary oedema - one of
whom received a fluid challenge and the other not - precluding
any meaningful analysis.
A recent large study in African children withsevere malaria given
fluid boluses of both saline and colloid solutions in a resource poor
setting provided clear evidence of harm with vigorous fluid loading
[14]. Children with severe malaria given a fluid load of 20–40 ml/
kg had a relative risk of death of 1.59 when compared to patients
given maintenance fluids. While there are some differences between
the clinical presentation of adults and children severe malaria, the
fundamental pathophysiology of the disease is similar. Our findings,
when added to the findings in the African children, would certainly
support caution in fluid resuscitation and would appear to add
weight to the old malariologist’s adage to ‘‘run them dry’’.
Conversely, aggressive fluid rehydration has been shown to be
highly effective in the management of Dengue haemorrhagic fever
in resource poor settings [5] and is a key tenet of the Surviving
Sepsis Guidelines for the management of patients with sepsis in
well resourced health settings [10]. In the study of African
children, those with severe malnutrition, gastroenteritis, non-
infectious causes of shock were excluded from randomisation in
the above study [14]. Early goal directed fluid resuscitation must
Table 4. Baseline demographics by resuscitation agent
(mean (95% CI)).
Variable Normal saline Gelofundin p value*
Age 37.3 (27.9–46.7) 34.3 (25 to 43.6) 0.67
Sex (male) % 12/12 (100%) 7/10 (70%) 0.08
Glasgow coma score 9 (6–11) 7 (5–9) 0.49
pH 7.39 (7.37–7.41) 7.30 (7.25–7.35) 0.004
HCO3(mmol/L) 16.6 (14.7–18.6) 11.5 (8.2–14.7) 0.009
Base deficit (mmol/L) 7.4 (5.3–9.5) 12.8 (9.2–16.4) 0.006
Lactate(arterial)(mmol/L) 4.4 (2.7–6.1) 8.1 (5–11.3) 0.03
Sodium (mmol/L) 132 (127–138) 132 (127–138) 0.84
Potassium (mmol/L) 4.4 (3.8–4.7) 3.8 (3.2–4.3) 0.07
Creatinine(mmol/L) 444 (285–602) 378 (204–551) 0.4
Total bilirubin (mmol/L) 142 (80–204) 115 (67–163) 0.64
Haemoglobin (g/dL) 9.4 (7.8–11) 8.3 (6.4–10.2) 0.11
Renal failure
Y 9/12 (75%) 8/10 (80%) 1
Anuric on admission
V 6/12 (50%) 4/10 (40%) 0.69
Shock on admission
# 1/12 (9%) 3/10 (30%) 0.29
Cerebral malaria‘ 10/12 (85%) 10/10 (100%) 0.48
APO on admission‘ 2/12 (17%) 1/10 (10%) 1
MABP(mmHg) 85 (79–92) 73 (65–81) 0.009
CVP(mmHg) 2 (1–3) 1 (0–2) 0.27
PAoP(mmHg) 5 (4–6) 5 (4–7) 0.64
Cardiac index(L/min/m
2) 4.32 (3.47–5.18) 3.87 (3.23–4.5) 0.45
CvO2 (%) 63.3 (59–67.6) 54 (45.9–62.1) 0.048
dO2 (mL/min/m
2) 497 (427–566) 405 (308–502) 0.09
SVRdyne/s/cm
25 m
2) 1707 (1275–2139) 1590 (1200–1980) 1
PaO2/FiO2 ratio 432 (341–524) 499 (403–595) 0.3
vO2 (mL/min/m
2) 166 (146–186) 164 (139–191) 0.57
O2er(%) 35 (30–39) 43.5 (34.9–52.1) 0.06
*p by Kruskal Wallis.
YAdmission serum creatinine.265 mmol/L.
V,50 ml urine output in first 24 hours.
#Systolic blood pressure ,80 mmHg with evidence of poor end organ
perfusion.
‘Clinical diagnosis.
APO: Acute pulmonary oedema, MABP: mean arterial blood pressure, MPAP:
Mean pulmonary artery pressure, CVP: central venous pressure, PAoP:
pulmonary artery occlusion pressure, SVR: systemic vascular resistance, SaO2:
oxygen saturation, CvO2: mixed venous oxygen saturation, DO2: oxygen
delivery, VO2: oxygen consumption, O2er: oxygen extraction ratio.
doi:10.1371/journal.pone.0025523.t004
Table 5. Outcomes by resuscitation agent.
Variable Normal saline Gelofundin p value*
Died 5/12 42% 3/10 30% 0.68
APO during hospitalisation‘ 0/12 7% 1/10 10% 0.46
ARF during hospitalisation
Y 1/12 9% 2/10 20% 0.57
Shock during hospitalisation‘ 3/12 25% 2/10 20% 1
*p by Fisher’s exact. APO: Acute pulmonary oedema,
‘Clinical diagnosis. ARF: Acute renal failure,
Yserum creatinine.265 mmol/L.
doi:10.1371/journal.pone.0025523.t005
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seems likely that when it comes to fluid resuscitation, there is no
one size that fits all.
The decision to fluid load patients, and the volume of fluid that
was administered, was on the basis of the PAoP, a parameter
strongly linked to the CVP. Since this study was performed, the
weight of clinical opinion has turned against a reliance on
pressure-based measures of preload to assess the patient’s volume
status. Neither CVP nor PAoP are good predictors of fluid
responsiveness in either healthy volunteers [31] or hypovolaemic
critically ill patients [32], and current opinion in the developed
world is that neither of these indices should be used to define the
state of ventricular filling or the potential of patients to respond to
a fluid challenge [33].
Figure 3. Relationship between baseline CVP and volume of fluid required to resuscitate patient (p=0.87 rs=0.04). Blue dots
survivors, red dots deaths.
doi:10.1371/journal.pone.0025523.g003
Table 6. Response to resuscitation agents (mean D (95% CI)).
Variable Normal saline Gelofundin p*
DMABP (mmHg) 0.2 (24.2–4.5) 6.1 (20.9–12.3) 0.19
DCVP (mmHg) 2 (0–4) 5 (3–7) 0.07
DPAoP (mmHg) 4 (2–7) 6 (4–8) 0.43
DCardiac index(L/min/m
2) 0.35 (0.1–0.61) 1.32 (0.69–1.94) 0.006
DDo2 (mL/min/m
2)4 ( 225–32) 50 (28–107) 0.11
DSVRI(dyne/s/cm
25 m
2) 2154 (2253–255) 2381(2706–257) 0.15
DSaO2 (%) 0 (0–1) 0 (21–1) 0.22
D PaO2/FiO2 ratio 25.7 (26.8–58.2) 238 (2106–28.4) 0.09
DHaemoglobin (g/dL)* 20.7 (21.5–20.2) 21.1 (22.6–0.2) 0.37
DCvO2 (%) 2.6 (21–6.2) 5.6 (0.12–11.2) 0.55
Dph 20.02 (20.04–20.01) 0 (20.03 20 .02) 0.08
DHCO3 (mmol/L) 20.4 (21.2–0.5) 20.2 (21.1–0.8) 0.78
Dbase deficit 21( 21.8–0.1) 20.3 (21.6–0.9) 0.46
DLactate (mmol/L) 0.2 (20.6–1) 20.1 (21–0.8) 0.7
DVo2 (mL/min/m
2) 212 (233–10) 28( 233–17) 0.74
DO2er (%) 22.3 (26–1.3) 26( 211.8–0.2) 0.32
*p by Kruskal Wallis. MABP: mean arterial blood pressure, CVP: central venous pressure, PAoP: pulmonary artery occlusion pressure, SVRI: systemic vascular resistance
index, SaO2: oxygen saturation, CvO2: mixed venous oxygen saturation, DO2: oxygen delivery, VO2: oxygen consumption, O2ER: oxygen extraction ratio.
doi:10.1371/journal.pone.0025523.t006
Fluid Management of Adults with Severe Malaria
PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e25523In this small series, there was no correlation between point
measures of CVP and PAoP and cardiac index, oxygen delivery
or acid base status, before or after fluid resuscitation. In addition
to the observations about the potential limitations of CVP and
PAoP being used as targets for resuscitation, there was no
relationship between the CVP and PAoP and the presence of
pulmonary oedema. There was also no relationship between the
CVP/PAoP and the PaO2/FiO2 ratio. This accords with
previous studies that have identified little correlation between
pulmonary oedema and CVP [34] or PAoP [30] and is consistent
with the hypothesis that pulmonary oedema in severe malaria is
predominantly the result of increased pulmonary capillary
permeability.
Whilst central lines offer secure access and a conduit for the
administration of veno-irritant drugs, they are relatively expensive
and may be associated with serious complications during insertion
and maintenance [35]. In view of the limited benefit that they
appear to provide the clinician in managing the patient with severe
malaria in this and other series, the WHO recommendation to use
them should perhaps be attenuated.
Analysing the effect of the type of fluid administered is difficult,
as at baseline the patients who received gelofundin were sicker
than the patients who received saline. They had a lower pH,
MABP, base deficit, a higher lactate, and would be expected to
have a higher mortality rate; but there was no significant
difference in mortality. The patients who received gelofundin
had a significantly greater increase in their cardiac index and a
trend to an increased oxygen delivery, although there were no
changes in base deficit and bicarbonate.
There are several flaws in our retrospective study that prevent
the generation of strong recommendations based on its findings.
The first and most obvious is that the small sample size limits the
power of the study to detect subtle differences between the various
groups. The patients were managed according to clinical
judgement rather than via a defined protocol. Although renal
failure is a common complication of severe malaria, the median
serum creatinine in this series of 309 mmol/L (95% CI 226–414) is
much higher than in other series; indeed 44% of the patients were
anuric on admission. Patients with renal impairment might be
expected to handle a fluid load poorly and thus our observation
that these patients had little benefit from fluid loading, may reflect
their renal impairment rather than any haemodynamic manifes-
tations of their severe malaria. The number of patients with severe
renal dysfunction also complicates interpretation of the acid-base
data. Most patients in the series received quinine or intramuscular
artemether as their anti-malarial drug treatment – both therapies
have now been superseded by intravenous artesunate - and thus
the mortality in the series is higher than would be expected if the
Figure 4. Relationship between change in base deficit against change in cardiac index with fluid loading (p=0.95 rs=0.01). Blue dots
survivors, red dots deaths.
doi:10.1371/journal.pone.0025523.g004
Table 7. Correlation between DCVP and DPAoP.
Variable CVPD Rho* PAoPD Rho*
LactateD 0.56 20.13 0.71 20.08
BDD 0.88 0.03 0.62 0.13
HCO3D 0.59 20.14 0.85 20.05
CID 0.06 0.39 0.44 0.16
DO2D 0.98 0.01 0.74 0.07
VO2D 0.8 0.05 0.66 0.1
O2erD 0.69 20.08 0.66 0.1
CvO2D 0.58 0.12 0.76 20.07
MABPD 0.13 0.32 0.5 0.14
*Spearman’s rho, p value by Spearman’s.
CVP: Central venous pressure, PAoP: Pulmonary artery occlusion pressure, BD:
base deficit, HCO3: Bicarbonate. CI: cardiac index, DO2: Oxygen delivery, VO2:
oxygen consumption, O2er: oxygen extraction ratio, CvO2: central mixed venous
oxygen saturation, MABP: mean arterial blood pressure.
doi:10.1371/journal.pone.0025523.t007
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aggressive fluid resuscitation emphasize the importance of early
treatment. While patients presenting in shock, or established organ
failure is representative of the real world where they will be
managed, it may be that in our study by the time resuscitation was
commenced, the damage had been done.
Despite these caveats there are several observations worth
making. The first is that while almost all adults with severe malaria
will require intravenous fluids, the results of this study do not
predict significant improvements in acid base status and outcomes
as a result of this fluid resuscitation. The role of fluid resuscitation
remains unclear, and although many will have true or at least
effective hypovolaemia on admission, a more conservative fluid
regimen may turn out to be preferable, as has been demonstrated
in other patients with ARDS and septic shock [36] and was the
unexpected outcome of the recent large fluids trial in African
children with malaria [14].
Despite malaria claiming the lives of thousands of adults every
year, relatively little is known about the optimal supportive
therapies for these patients. The vast majority of patients with
severe malaria will be managed in a resource poor setting, often by
relatively inexperienced health care providers, with limited
intensive care support. Resuscitation protocols will need to be
tailored to this environment to provide appropriately easy to
implement, practical guidelines for these practitioners. However
the findings of this and other studies [14,24,25] suggest that while
aggressive fluid resuscitation is relatively cheap and easier to
administer in patients with severe malaria, it may be that the
search for adjuvant therapy would be more fruitfully conducted at
the microvascular level.
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